Predict your next investment

HEALTHCARE | Medical Product Distribution
innovabiosciences.com

See what CB Insights has to offer

Stage

Acquired - II | Acquired

About Innova Biosciences

Innova Biosciences develops, manufactures and commercializes labeling reagents that are marketed worldwide by its direct salesforce as well as through a distribution network. On November 11, 2019, Innova Biosciences was acquired by Abcam, terms of the agreement were not disclosed.

Innova Biosciences Headquarter Location

Babraham Hall Babraham

Cambridge, England, CB22 3AT,

United Kingdom

+44 (0) 1223 750 039

Latest Innova Biosciences News

Abcam acquires Expedeon's Proteomics and Immunology business

Jan 17, 2020

Friday, 17 January, 2020 Abcam , a global innovator in life science reagents and tools, has announced the successful completion of the acquisition of Expedeon ’s Proteomics and Immunology business, which includes Innova Biosciences and TGR BioSciences, as of 1 January 2020. Abcam and Expedeon say they are fully committed to providing continued access to Expedeon’s proteomics and immunology products and support so that the life science community can perform their research and development without interruption. Proteomics research requires the use of molecular labels that are covalently attached to a protein of interest to facilitate detection or purification of the protein or its binding partners. With conjugation kits for over 50 types of labels for applications across the life science industry, Expedeon’s technology supports a diverse set of labels, including enzymes, metals, oligos and fluorescent proteins. Abcam will combine the newly acquired capture and conjugation technologies with its extensive antibody and protein expertise to expand and enhance its portfolio of off-the-shelf and custom reagents and tools. The news comes two months after Abcam announced a strategic partnership with BrickBio , a biotech company specialising in site-specific protein modification, covering the use of the latter’s proprietary platform for introducing conjugation-ready sites into antibodies and other proteins in both mammalian and bacterial expression systems. “Our reputation as an innovator in the field of biological reagents, coupled with our dedicated global commercialisation infrastructure, will allow us to make these technologies readily available globally,” said Dr John Baker, SVP Product Portfolio and Innovation, Abcam. “We have had teams working on conjugation for several years and the combination of this expertise with the Expedeon portfolio and other complementary conjugation technologies, including BrickBio’s, provides a very powerful platform to enable us to deliver the precision research tools required to address the majority of life science assays used today and those emerging in the future.” Please follow us and share on Twitter and Facebook . You can also subscribe for FREE to our weekly newsletters and bimonthly magazine. Related News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Innova Biosciences Patents

Innova Biosciences has filed 5 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/30/2014

6/29/2021

Molecular biology, Biotechnology, Proteins, Immunology, Carboxylate esters

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/30/2014

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/29/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Biotechnology, Proteins, Immunology, Carboxylate esters

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.